Viking Therapeutics Stock (NASDAQ:VKTX), Quotes and News Summary

Q: What sector and industry does Viking Therapeutics (VKTX) operate in?

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viking Therapeutics Stock (NASDAQ: VKTX) stock price, news, charts, stock research, profile.

Open	$66.850
Close	$67.515
Volume / Avg.	2.484M / 6.352M
Day Range	66.180 - 68.530
52 Wk Range	8.280 - 99.410
Market Cap	$7.441B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	14.8%
Days to Cover	4.61

Recent News

4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly

The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021.

Zacks

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

The Benzinga Stock Whisper highlights five stocks weekly that are seeing increased interest from readers.

Chris Katje

Should You Hold Viking Therapeutics in Your Portfolio?

Viking Therapeutics (NASDAQ: VKTX), a clinical-stage company focused on developing novel therapeutics for metabolic and endocrine disorders, has been in the news, owing to updates from its obesity program.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Viking Therapeutics (VKTX) stock?

You can purchase shares of Viking Therapeutics (NASDAQ: VKTX) through any online brokerage.

View our list of the best stock brokerages.

Who are Viking Therapeutics's (VKTX) competitors?

Other companies in Viking Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for Viking Therapeutics (VKTX) stock?

The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Raymond James on Thursday, May 16, 2024. The analyst firm set a price target for 116.00 expecting VKTX to rise to within 12 months (a possible 71.90% upside). 25 analyst firms have reported ratings in the last year.

Current Stock Price for Viking Therapeutics (VKTX)?

The stock price for Viking Therapeutics (NASDAQ: VKTX) is $67.4814 last updated May 20, 2024 at 7:59 PM EDT.

Does Viking Therapeutics (VKTX) pay a dividend?

There are no upcoming dividends for Viking Therapeutics.

When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?

Viking Therapeutics’s Q2 earnings are confirmed for Wednesday, July 24, 2024.

Is Viking Therapeutics (VKTX) going to split?

There is no upcoming split for Viking Therapeutics.

What sector and industry does Viking Therapeutics (VKTX) operate in?

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-